Vascular Cell Therapy
We treat the cause of vascular disease not the symptoms
Vascular disorders include chronic wounds that impact millions of individuals globally, with a substantial number showing resistance to conventional therapies.
​
Our focus is on creating regenerative medical solutions to meet the unaddressed requirements in this patient population.
Our Treatments
Critical Limb Ischemia
Worldwide, >200 million people have Peripheral Artery Disease (PAD), surpassing the prevalence of AIDS, cancer, dementia, Alzheimer's, and heart failure.
Critical Limb Ischemia (CLI) is the most severe form of PAD. Prognosis is grim, with about 50% of patients experiencing cardiovascular-related fatalities within 5 years.
Diabetic Foot
Diabetic Foot Ulcers (DFUs) are a pressing healthcare challenge, characterised by their non-healing nature, incurable status, and devastating impact on patients often leading to prolonged suffering for individuals with diabetes, .
​
Pressure Ulcers
Pressure ulcers, or bedsores, are caused by prolonged pressure on the skin and tissues, leading to pain, discomfort, and a heightened infection risk.
Revolutionizing the Healthcare Industry
At ReproGo, we believe that everyone deserves access to the best possible healthcare.
Regenerative medicine holds promise as a novel avenue for people grappling with incurable degenerative ailments. ReproGo is dedicated to propelling cell therapies that aim to rejuvenate functionality in tissues experiencing a depletion of blood flow, known as 'ischemia.'
The use of induced pluripotent stem cell (iPSC) technology serves as an optimal foundation for reliable, sustainable and scalable production of regenerative medicine products. Leveraging our exclusive cell differentiation technology, we can derive distinctive products through this innovative approach.